|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total prepaid expenses | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable Investments | ||||||||||||||||||||
| Digital assets | ||||||||||||||||||||
| Prepaid R&D services- related party (see Note 8 and Note 13) | ||||||||||||||||||||
| Prepaid R&D services (see Note 6) | ||||||||||||||||||||
| Prepaid R&D services | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Equity method investment | ||||||||||||||||||||
| SAFE Note investment | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Equipment and clinical assets, net | ||||||||||||||||||||
| Prepaid expenses and other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued professional fees | ||||||||||||||||||||
| Accrued payroll | ||||||||||||||||||||
| Investment payable | ||||||||||||||||||||
| Accrued expenses and other current liabilities | ||||||||||||||||||||
| Bank overdraft | ||||||||||||||||||||
| Accrued litigation liability | ||||||||||||||||||||
| Operating lease liability, current portion | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Deferred commission payable | ||||||||||||||||||||
| Convertible promissory note payable | ||||||||||||||||||||
| Convertible promissory notes payable at fair value | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible promissory notes payable at fair value | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total notes payable | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liability, non-current portion | ||||||||||||||||||||
| Derivative warrant liability | ||||||||||||||||||||
| Deferred commission payable | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity (deficit) | ||||||||||||||||||||
| Common stock, par value $0.0001; 250,000,000 shares authorized at September 30, 2026 and December 31, 2025, 73,866 and 18 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Total common stock, par value $0.0001; 250,000,000 shares authorized at September 30, 2026 and December 31, 2025, 73,866 and 18 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock; 11,713 shares and nil shares issued at June 30, 2025 and December 31, 2024, respectively, at cost | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| Total liabilities and stockholders’ equity (deficit) | ||||||||||||||||||||
Loading...